Bioequivalence study in Multiple countries [Study Per­for­mance]

posted by Achievwin – US, 2025-02-21 03:02 (64 d 15:52 ago) – Posting: # 24370
Views: 898

Hello:

I want to see if anyone have an experience in running bioequivalence study in patients across more than one geographic region (Asia and Europe, Asia, North America Asia Mexico/Middle East). Usually BE studies are quick and confined to one country and uniform demographic population. Want to know are there any advantages or challenges in running a Bioequivalence study in multiple countries from the operational, compliance or any other issues.

Your feed back is highly appreciated as I am struggling with a patient population that is hard to recruit and retain.

Sincerely,

Achievwin

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
18 visitors (0 registered, 18 guests [including 1 identified bots]).
Forum time: 19:55 CEST (Europe/Vienna)

A drug is that substance which, when injected into a rat,
will produce a scientific report.    Anonymous

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5